No, CRISPR Is Not Going To ‘ Cure ’ Heart Disease
No, CRISPR gene editing technology is not going to “cure” heart disease. But a New York Times story by Gina Kolata on an extremely early study in animals prominently plays up just this extremely unlikely claim. The Times story is based on a press release issued by Verve Therapeutics, a new biotechnology company founded by Sekar Kathiresan, an influential cardiologist and genomic...Click here to continue reading...
Source: CardioBrief - Category: Cardiology Authors: Larry Husten Tags: People, Places & Events Policy & Ethics Prevention, Epidemiology & Outcomes CRISPR gene editing hype journalism LDL PCSK9 Source Type: blogs
More News: Biotechnology | Cardiology | Epidemiology | Genetics | Heart | Heart Disease | Medical Ethics | Study